Save 50% with Camzyos brand from Europe.
Non-english packaging is often present for European medicines- English label and English insert included. Plan in advance - allow us 7 days to ship this brand name medicine.
According to the European Medicines Agency, brand name Camzyos originating from Europe is manufactured at the following site(s): Bristol-Myers Squibb Pharmaceutical Operations, External Manufacturing Plaza 254 Blanchardstown Corporate Park 2 Dublin 15, D15 T867
Information about Camzyos (Mavacamten)
Camzyos is a prescription medication containing mavacamten, a selective inhibitor of cardiac myosin. It is primarily used to treat symptomatic adults with obstructive hypertrophic cardiomyopathy (HCM), a condition where the heart muscle becomes abnormally thick and obstructs blood flow. By modulating the interaction between cardiac myosin and actin, mavacamten helps to improve heart muscle relaxation and reduce the obstruction.
Product Highlights
- Targets cardiac myosin, a protein involved in muscle contraction, to improve heart function and reduce symptoms of HCM.
- Specifically designed to address the underlying mechanism of obstructive HCM.
- Available in tablet form, providing a convenient method of administration.
Key Ingredient
Key Benefits
- Helps to alleviate symptoms of obstructive HCM, such as shortness of breath and chest pain.
- Reduces the obstruction caused by thickened heart muscle, enhancing overall heart function and exercise capacity.
- Targets the specific pathophysiological process in HCM, potentially leading to significant improvements in quality of life for patients.
Direction of Use
- The typical starting dose is 5 mg once daily, which may be adjusted based on clinical response and tolerability. Follow the specific dosage prescribed by your healthcare provider.
- Take the tablets orally with or without food. Swallow the tablets whole; do not crush or chew them.
- Take the medication at the same time each day to maintain consistent levels in your bloodstream and ensure the best results.
Safety Concerns
- May include headache, dizziness, fatigue, and gastrointestinal symptoms such as nausea or diarrhea.
- Watch for more severe reactions such as significant decreases in blood pressure, worsening heart failure symptoms, or allergic reactions. Report symptoms like severe dizziness, fainting, or swelling to your healthcare provider immediately.
- Mavacamten can interact with other medications, including certain heart medications and drugs that affect liver enzymes. Inform your healthcare provider of all other medications and supplements you are taking.
Avoid Camzyos (Mavacamten) If
- You are allergic to mavacamten or any of its inactive ingredients.
- Avoid use if you have certain severe heart conditions that may be exacerbated by the medication, such as advanced heart failure or significant left ventricular outflow tract obstruction.
- Those with severe liver impairment may need to avoid or use mavacamten under strict medical supervision due to potential alterations in drug metabolism.
- The safety of mavacamten during pregnancy has not been established. Consult your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.
